2024 ICD-10-CM Diagnosis Code T47.5X1S
Poisoning by digestants, accidental (unintentional), sequela
- ICD-10-CM Code:
- T47.5X1S
- ICD-10 Code for:
- Poisoning by digestants, accidental (unintentional), sequela
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
T47.5X1S is a billable diagnosis code used to specify a medical diagnosis of poisoning by digestants, accidental (unintentional), sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T47.5X1S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like poisoning by digestants accidental (unintentional). According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Accidental bile acid and/or bile acid derivative overdose
- Accidental bile acid and/or bile acid derivative poisoning
- Accidental ingestion of peppermint oil
- Accidental ingestion of toxic plant oil
- Bile acid and/or bile acid derivative overdose
- Bile acid and/or bile acid derivative poisoning
- Papain poisoning
- Pepsin poisoning
- Poisoning by pancreatin
Clinical Classification
Clinical Category is Poisoning/toxic effect/adverse effects/underdosing, sequela
- CCSR Category Code: INJ075
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
Betaine
a naturally occurring compound that has been of interest for its role in osmoregulation. as a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (from martindale, the extra pharmacopoeia, 30th ed, p1341)Betaine-Aldehyde Dehydrogenase
an nad+ dependent enzyme that catalyzes the oxidation of betain aldehyde to betaine.Betaine-Homocysteine S-Methyltransferase
a zinc metalloenzyme that catalyzes the transfer of a methyl group from betaine to homocysteine to produce dimethylglycine and methionine, respectively. this enzyme is a member of a family of zinc-dependent methyltransferases that use thiols or selenols as methyl acceptors.Chenodeoxycholic Acid
a bile acid, usually conjugated with either glycine or taurine. it acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. it is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.Cholic Acid
a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. it facilitates fat absorption and cholesterol excretion.Cholic Acids
the 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. they act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.Citric Acid
a key intermediate in metabolism. it is an acid compound found in citrus fruits. the salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.Citric Acid Cycle
a series of oxidative reactions in the breakdown of acetyl units derived from glucose; fatty acids; or amino acids by means of tricarboxylic acid intermediates. the end products are carbon dioxide, water, and energy in the form of phosphate bonds.Dehydrocholic Acid
a semisynthetic bile acid made from cholic acid. it is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.Asarum
a plant genus of the family aristolochiaceae which was used medicinally by north american indians. the common name of 'snakeroot' is also used for many other plants, including sanicula; or aristolochia; or polygala.Ginger
deciduous plant rich in volatile oil (oils, volatile). it is used as a flavoring agent and has many other uses both internally and topically.Glutamate Decarboxylase
a pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of l-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. the enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. it is the rate-limiting enzyme in determining gamma-aminobutyric acid levels in normal nervous tissues. the brain enzyme also acts on l-cysteate, l-cysteine sulfinate, and l-aspartate. ec 4.1.1.15.Glutamates
derivatives of glutamic acid. included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure.Glutamic Acid
a non-essential amino acid naturally occurring in the l-form. glutamic acid is the most common excitatory neurotransmitter in the central nervous system.Plasminogen
precursor of plasmin (fibrinolysin). it is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. it is used in wound debriding and has been investigated as a thrombolytic agent.RNA, Transfer, Glu
a transfer rna which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.Pancreatin
a mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. it is used as a digestant in pancreatic malfunction.Pancrelipase
a preparation of hog pancreatic enzymes standardized for lipase content.Coronavirus Papain-Like Proteases
papain-like proteases that occur in species of coronaviridae. some species have more than one papain-like protease gene.Papain
a proteolytic enzyme obtained from carica papaya. it is also the name used for a purified mixture of papain and chymopapain that is used as a topical enzymatic debriding agent. ec 3.4.22.2.
Coding Guidelines
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Present on Admission (POA)
T47.5X1S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert T47.5X1S to ICD-9-CM
- ICD-9-CM Code: 909.0 - Late eff drug poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment. - ICD-9-CM Code: E929.2 - Late eff acc poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
Table of Drugs and Chemicals
The parent code T47.5X1 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Medication Errors
Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:
- Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
- Keeping a list of medicines.
- Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
- List the medicines that you are allergic to or that have caused you problems in the past.
- Take this list with you every time you see a health care provider.
- Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
- Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
- Why am I taking this medicine?
- What are the common side effects?
- What should I do if I have side effects?
- When should I stop this medicine?
- Can I take this medicine with the other medicines and supplements on my list?
- Do I need to avoid certain foods or alcohol while taking this medicine?
Food and Drug Administration
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.